SI

Sofinnova Investments Portfolio holdings

AUM $2.32B
1-Year Est. Return 101.65%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+101.65%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.32B
AUM Growth
+$689M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
70
New
Increased
Reduced
Closed

Top Buys

1
+$72.8M
2
+$70.9M
3
+$59M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$56.9M
5
ABBV icon
AbbVie
ABBV
+$38M

Top Sells

1
+$139M
2
+$55.6M
3
+$53.2M
4
ROIV icon
Roivant Sciences
ROIV
+$47.6M
5
DXCM icon
DexCom
DXCM
+$26M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXSM icon
51
Axsome Therapeutics
AXSM
$7.88B
$2.24M 0.1%
12,266
-381,233
ESTA icon
52
Establishment Labs
ESTA
$1.86B
$2.07M 0.09%
28,366
+17,579
RARE icon
53
Ultragenyx Pharmaceutical
RARE
$2.1B
$1.92M 0.08%
+83,300
SVRA icon
54
Savara
SVRA
$1.08B
$1.84M 0.08%
304,770
-2,122,954
MIRM icon
55
Mirum Pharmaceuticals
MIRM
$5.42B
$1.82M 0.08%
+23,100
ACAD icon
56
Acadia Pharmaceuticals
ACAD
$3.63B
$1.75M 0.08%
65,567
+38,767
JBIO
57
Jade Biosciences
JBIO
$683M
$1.66M 0.07%
107,391
BOLT icon
58
Bolt Biotherapeutics
BOLT
$7.77M
$753K 0.03%
137,721
SLNO icon
59
Soleno Therapeutics
SLNO
$1.9B
$575K 0.02%
12,414
-153,867
IMA
60
ImageneBio Inc
IMA
$67.1M
$220K 0.01%
31,884
MRUS
61
DELISTED
Merus
MRUS
– –
-166,729
PTCT icon
62
PTC Therapeutics
PTCT
$5.24B
– –
-186,932
SMMT icon
63
Summit Therapeutics
SMMT
$12B
– –
0
SRRK icon
64
Scholar Rock
SRRK
$4.8B
– –
-31,410
XBI icon
65
State Street SPDR S&P Biotech ETF
XBI
$7.78B
– –
0
AKRO
66
DELISTED
Akero Therapeutics
AKRO
– –
-473,625
BSX icon
67
Boston Scientific
BSX
$102B
– –
-569,427
GILD icon
68
Gilead Sciences
GILD
$180B
– –
-1,252,312
IBB icon
69
iShares Biotechnology ETF
IBB
$8.24B
– –
0
LQDA icon
70
Liquidia Corp
LQDA
$3.27B
– –
0
1 2
3